Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients
Abstract Background The role of laparoscopic adrenalectomy in the treatment of patients with adrenocortical carcinoma (ACC) is controversial. Objective Our aim was to compare oncologic outcome in patients with ACC who underwent either open adrenalectomy (OA) or laparoscopic adrenalectomy (LA) for lo...
Gespeichert in:
Veröffentlicht in: | European urology 2010-10, Vol.58 (4), p.609-615 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 615 |
---|---|
container_issue | 4 |
container_start_page | 609 |
container_title | European urology |
container_volume | 58 |
creator | Brix, David Allolio, Bruno Fenske, Wiebke Agha, Ayman Dralle, Henning Jurowich, Christian Langer, Peter Mussack, Thomas Nies, Christoph Riedmiller, Hubertus Spahn, Martin Weismann, Dirk Hahner, Stefanie Fassnacht, Martin |
description | Abstract Background The role of laparoscopic adrenalectomy in the treatment of patients with adrenocortical carcinoma (ACC) is controversial. Objective Our aim was to compare oncologic outcome in patients with ACC who underwent either open adrenalectomy (OA) or laparoscopic adrenalectomy (LA) for localised disease. Design, setting, and participants We conducted a retrospective analysis of 152 patients with stage I–III ACC with a tumour ≤10 cm registered with the German ACC Registry. Intervention Patients were stratified into two groups according to the surgical procedure (LA or OA). For comparison, we used both a matched pairs approach by selecting for each patient from the LA group ( n = 35) one corresponding patient from the OA group ( n = 117) and multivariate analysis in all 152 patients. Measurements Disease-specific survival was chosen as the predefined primary end point. Secondary end points were recurrence-free survival, frequency of tumour capsule violation and postoperative peritoneal carcinomatosis, and incidence and reasons for conversion from LA to OA. Results and limitations LA and OA did not differ with regard to the primary end point using either the matched pairs approach (hazard ratio [HR] for death: 0.79; 95% confidence interval [CI], 0.36–1.72; p = 0.55) or multivariate analysis (HR for death: 0.98; 95% CI, 0.51–1.92; p = 0.92). Similarly, adjusted recurrence-free survival was not different between LA and OA (HR: 0.91; 95% CI, 0.56–1.47; p = 0.69). Frequency of tumour capsule violation and peritoneal carcinomatosis were comparable between groups. In 12 of 35 patients of the LA group, surgery was converted to open surgery with no impact on the clinical outcome. Conclusions For localised ACC with a diameter of ≤10 cm, LA by an experienced surgeon is not inferior to OA with regard to oncologic outcome. |
doi_str_mv | 10.1016/j.eururo.2010.06.024 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754028498</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0302283810005579</els_id><sourcerecordid>754028498</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-d02afc23828aac8d5a2bd5a6d257f7a7fff6bd7905f4f2c110289f309b11e9cc3</originalsourceid><addsrcrecordid>eNpFkV2P1CAUhonRuOPqPzCGG-NVxwOUlnphspn4sckks8mu3hKGgmFsoUIxmX8vtaN7A-HNc4A8L0KvCWwJkOb9aWtyzDFsKZQImi3Q-gnaENGyquUNPEUbYEArKpi4Qi9SOgEA4x17jq4ocAG14BuU9mpSMSQdJqfxdxNTTvgwGY9v-mi8Goyew3jGNsQ1CTrE2Wk14J2K2vkwqg_4PscffzPle3zwOgyhnPEhzzqMBjuPCaf4Ts3O-Dm9RM-sGpJ5ddmv0bfPnx52X6v94cvt7mZfadaRueqBKqspE1QopUXPFT2Wpekpb22rWmttc-zbDritLdWEABWdZdAdCTGd1uwavVvvnWL4lU2a5eiSNsOgvAk5yZbXZaTuRCHrldRFRYrGyim6UcWzJCAX2_IkV9tysS2hkcV2GXtzeSAfR9P_H_qntwBvL4BKRY-NymuXHjlWflzTrnAfV84UHb-diVIPzi9Gf5qzSaeQY6kiSSITlSDvl2KXXkmplPO2Y38AjpOgkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>754028498</pqid></control><display><type>article</type><title>Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Brix, David ; Allolio, Bruno ; Fenske, Wiebke ; Agha, Ayman ; Dralle, Henning ; Jurowich, Christian ; Langer, Peter ; Mussack, Thomas ; Nies, Christoph ; Riedmiller, Hubertus ; Spahn, Martin ; Weismann, Dirk ; Hahner, Stefanie ; Fassnacht, Martin</creator><creatorcontrib>Brix, David ; Allolio, Bruno ; Fenske, Wiebke ; Agha, Ayman ; Dralle, Henning ; Jurowich, Christian ; Langer, Peter ; Mussack, Thomas ; Nies, Christoph ; Riedmiller, Hubertus ; Spahn, Martin ; Weismann, Dirk ; Hahner, Stefanie ; Fassnacht, Martin ; German Adrenocortical Carcinoma Registry Group</creatorcontrib><description>Abstract Background The role of laparoscopic adrenalectomy in the treatment of patients with adrenocortical carcinoma (ACC) is controversial. Objective Our aim was to compare oncologic outcome in patients with ACC who underwent either open adrenalectomy (OA) or laparoscopic adrenalectomy (LA) for localised disease. Design, setting, and participants We conducted a retrospective analysis of 152 patients with stage I–III ACC with a tumour ≤10 cm registered with the German ACC Registry. Intervention Patients were stratified into two groups according to the surgical procedure (LA or OA). For comparison, we used both a matched pairs approach by selecting for each patient from the LA group ( n = 35) one corresponding patient from the OA group ( n = 117) and multivariate analysis in all 152 patients. Measurements Disease-specific survival was chosen as the predefined primary end point. Secondary end points were recurrence-free survival, frequency of tumour capsule violation and postoperative peritoneal carcinomatosis, and incidence and reasons for conversion from LA to OA. Results and limitations LA and OA did not differ with regard to the primary end point using either the matched pairs approach (hazard ratio [HR] for death: 0.79; 95% confidence interval [CI], 0.36–1.72; p = 0.55) or multivariate analysis (HR for death: 0.98; 95% CI, 0.51–1.92; p = 0.92). Similarly, adjusted recurrence-free survival was not different between LA and OA (HR: 0.91; 95% CI, 0.56–1.47; p = 0.69). Frequency of tumour capsule violation and peritoneal carcinomatosis were comparable between groups. In 12 of 35 patients of the LA group, surgery was converted to open surgery with no impact on the clinical outcome. Conclusions For localised ACC with a diameter of ≤10 cm, LA by an experienced surgeon is not inferior to OA with regard to oncologic outcome.</description><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2010.06.024</identifier><identifier>PMID: 20580485</identifier><identifier>CODEN: EUURAV</identifier><language>eng</language><publisher>Kidlington: Elsevier</publisher><subject>Adrenal Cortex Neoplasms - surgery ; Adrenalectomy - methods ; Adrenals. Adrenal axis. Renin-angiotensin system (diseases) ; Adrenocortical Carcinoma - surgery ; Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Endocrinopathies ; Female ; Humans ; Laparoscopy ; Male ; Malignant tumors ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Retrospective Studies ; Treatment Outcome ; Urology ; Young Adult</subject><ispartof>European urology, 2010-10, Vol.58 (4), p.609-615</ispartof><rights>European Association of Urology</rights><rights>2015 INIST-CNRS</rights><rights>Copyright 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-d02afc23828aac8d5a2bd5a6d257f7a7fff6bd7905f4f2c110289f309b11e9cc3</citedby><cites>FETCH-LOGICAL-c391t-d02afc23828aac8d5a2bd5a6d257f7a7fff6bd7905f4f2c110289f309b11e9cc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23289429$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20580485$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brix, David</creatorcontrib><creatorcontrib>Allolio, Bruno</creatorcontrib><creatorcontrib>Fenske, Wiebke</creatorcontrib><creatorcontrib>Agha, Ayman</creatorcontrib><creatorcontrib>Dralle, Henning</creatorcontrib><creatorcontrib>Jurowich, Christian</creatorcontrib><creatorcontrib>Langer, Peter</creatorcontrib><creatorcontrib>Mussack, Thomas</creatorcontrib><creatorcontrib>Nies, Christoph</creatorcontrib><creatorcontrib>Riedmiller, Hubertus</creatorcontrib><creatorcontrib>Spahn, Martin</creatorcontrib><creatorcontrib>Weismann, Dirk</creatorcontrib><creatorcontrib>Hahner, Stefanie</creatorcontrib><creatorcontrib>Fassnacht, Martin</creatorcontrib><creatorcontrib>German Adrenocortical Carcinoma Registry Group</creatorcontrib><title>Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients</title><title>European urology</title><addtitle>Eur Urol</addtitle><description>Abstract Background The role of laparoscopic adrenalectomy in the treatment of patients with adrenocortical carcinoma (ACC) is controversial. Objective Our aim was to compare oncologic outcome in patients with ACC who underwent either open adrenalectomy (OA) or laparoscopic adrenalectomy (LA) for localised disease. Design, setting, and participants We conducted a retrospective analysis of 152 patients with stage I–III ACC with a tumour ≤10 cm registered with the German ACC Registry. Intervention Patients were stratified into two groups according to the surgical procedure (LA or OA). For comparison, we used both a matched pairs approach by selecting for each patient from the LA group ( n = 35) one corresponding patient from the OA group ( n = 117) and multivariate analysis in all 152 patients. Measurements Disease-specific survival was chosen as the predefined primary end point. Secondary end points were recurrence-free survival, frequency of tumour capsule violation and postoperative peritoneal carcinomatosis, and incidence and reasons for conversion from LA to OA. Results and limitations LA and OA did not differ with regard to the primary end point using either the matched pairs approach (hazard ratio [HR] for death: 0.79; 95% confidence interval [CI], 0.36–1.72; p = 0.55) or multivariate analysis (HR for death: 0.98; 95% CI, 0.51–1.92; p = 0.92). Similarly, adjusted recurrence-free survival was not different between LA and OA (HR: 0.91; 95% CI, 0.56–1.47; p = 0.69). Frequency of tumour capsule violation and peritoneal carcinomatosis were comparable between groups. In 12 of 35 patients of the LA group, surgery was converted to open surgery with no impact on the clinical outcome. Conclusions For localised ACC with a diameter of ≤10 cm, LA by an experienced surgeon is not inferior to OA with regard to oncologic outcome.</description><subject>Adrenal Cortex Neoplasms - surgery</subject><subject>Adrenalectomy - methods</subject><subject>Adrenals. Adrenal axis. Renin-angiotensin system (diseases)</subject><subject>Adrenocortical Carcinoma - surgery</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Humans</subject><subject>Laparoscopy</subject><subject>Male</subject><subject>Malignant tumors</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Urology</subject><subject>Young Adult</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkV2P1CAUhonRuOPqPzCGG-NVxwOUlnphspn4sckks8mu3hKGgmFsoUIxmX8vtaN7A-HNc4A8L0KvCWwJkOb9aWtyzDFsKZQImi3Q-gnaENGyquUNPEUbYEArKpi4Qi9SOgEA4x17jq4ocAG14BuU9mpSMSQdJqfxdxNTTvgwGY9v-mi8Goyew3jGNsQ1CTrE2Wk14J2K2vkwqg_4PscffzPle3zwOgyhnPEhzzqMBjuPCaf4Ts3O-Dm9RM-sGpJ5ddmv0bfPnx52X6v94cvt7mZfadaRueqBKqspE1QopUXPFT2Wpekpb22rWmttc-zbDritLdWEABWdZdAdCTGd1uwavVvvnWL4lU2a5eiSNsOgvAk5yZbXZaTuRCHrldRFRYrGyim6UcWzJCAX2_IkV9tysS2hkcV2GXtzeSAfR9P_H_qntwBvL4BKRY-NymuXHjlWflzTrnAfV84UHb-diVIPzi9Gf5qzSaeQY6kiSSITlSDvl2KXXkmplPO2Y38AjpOgkw</recordid><startdate>20101001</startdate><enddate>20101001</enddate><creator>Brix, David</creator><creator>Allolio, Bruno</creator><creator>Fenske, Wiebke</creator><creator>Agha, Ayman</creator><creator>Dralle, Henning</creator><creator>Jurowich, Christian</creator><creator>Langer, Peter</creator><creator>Mussack, Thomas</creator><creator>Nies, Christoph</creator><creator>Riedmiller, Hubertus</creator><creator>Spahn, Martin</creator><creator>Weismann, Dirk</creator><creator>Hahner, Stefanie</creator><creator>Fassnacht, Martin</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101001</creationdate><title>Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients</title><author>Brix, David ; Allolio, Bruno ; Fenske, Wiebke ; Agha, Ayman ; Dralle, Henning ; Jurowich, Christian ; Langer, Peter ; Mussack, Thomas ; Nies, Christoph ; Riedmiller, Hubertus ; Spahn, Martin ; Weismann, Dirk ; Hahner, Stefanie ; Fassnacht, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-d02afc23828aac8d5a2bd5a6d257f7a7fff6bd7905f4f2c110289f309b11e9cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adrenal Cortex Neoplasms - surgery</topic><topic>Adrenalectomy - methods</topic><topic>Adrenals. Adrenal axis. Renin-angiotensin system (diseases)</topic><topic>Adrenocortical Carcinoma - surgery</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Humans</topic><topic>Laparoscopy</topic><topic>Male</topic><topic>Malignant tumors</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Urology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brix, David</creatorcontrib><creatorcontrib>Allolio, Bruno</creatorcontrib><creatorcontrib>Fenske, Wiebke</creatorcontrib><creatorcontrib>Agha, Ayman</creatorcontrib><creatorcontrib>Dralle, Henning</creatorcontrib><creatorcontrib>Jurowich, Christian</creatorcontrib><creatorcontrib>Langer, Peter</creatorcontrib><creatorcontrib>Mussack, Thomas</creatorcontrib><creatorcontrib>Nies, Christoph</creatorcontrib><creatorcontrib>Riedmiller, Hubertus</creatorcontrib><creatorcontrib>Spahn, Martin</creatorcontrib><creatorcontrib>Weismann, Dirk</creatorcontrib><creatorcontrib>Hahner, Stefanie</creatorcontrib><creatorcontrib>Fassnacht, Martin</creatorcontrib><creatorcontrib>German Adrenocortical Carcinoma Registry Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brix, David</au><au>Allolio, Bruno</au><au>Fenske, Wiebke</au><au>Agha, Ayman</au><au>Dralle, Henning</au><au>Jurowich, Christian</au><au>Langer, Peter</au><au>Mussack, Thomas</au><au>Nies, Christoph</au><au>Riedmiller, Hubertus</au><au>Spahn, Martin</au><au>Weismann, Dirk</au><au>Hahner, Stefanie</au><au>Fassnacht, Martin</au><aucorp>German Adrenocortical Carcinoma Registry Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2010-10-01</date><risdate>2010</risdate><volume>58</volume><issue>4</issue><spage>609</spage><epage>615</epage><pages>609-615</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><coden>EUURAV</coden><abstract>Abstract Background The role of laparoscopic adrenalectomy in the treatment of patients with adrenocortical carcinoma (ACC) is controversial. Objective Our aim was to compare oncologic outcome in patients with ACC who underwent either open adrenalectomy (OA) or laparoscopic adrenalectomy (LA) for localised disease. Design, setting, and participants We conducted a retrospective analysis of 152 patients with stage I–III ACC with a tumour ≤10 cm registered with the German ACC Registry. Intervention Patients were stratified into two groups according to the surgical procedure (LA or OA). For comparison, we used both a matched pairs approach by selecting for each patient from the LA group ( n = 35) one corresponding patient from the OA group ( n = 117) and multivariate analysis in all 152 patients. Measurements Disease-specific survival was chosen as the predefined primary end point. Secondary end points were recurrence-free survival, frequency of tumour capsule violation and postoperative peritoneal carcinomatosis, and incidence and reasons for conversion from LA to OA. Results and limitations LA and OA did not differ with regard to the primary end point using either the matched pairs approach (hazard ratio [HR] for death: 0.79; 95% confidence interval [CI], 0.36–1.72; p = 0.55) or multivariate analysis (HR for death: 0.98; 95% CI, 0.51–1.92; p = 0.92). Similarly, adjusted recurrence-free survival was not different between LA and OA (HR: 0.91; 95% CI, 0.56–1.47; p = 0.69). Frequency of tumour capsule violation and peritoneal carcinomatosis were comparable between groups. In 12 of 35 patients of the LA group, surgery was converted to open surgery with no impact on the clinical outcome. Conclusions For localised ACC with a diameter of ≤10 cm, LA by an experienced surgeon is not inferior to OA with regard to oncologic outcome.</abstract><cop>Kidlington</cop><pub>Elsevier</pub><pmid>20580485</pmid><doi>10.1016/j.eururo.2010.06.024</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0302-2838 |
ispartof | European urology, 2010-10, Vol.58 (4), p.609-615 |
issn | 0302-2838 1873-7560 |
language | eng |
recordid | cdi_proquest_miscellaneous_754028498 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adrenal Cortex Neoplasms - surgery Adrenalectomy - methods Adrenals. Adrenal axis. Renin-angiotensin system (diseases) Adrenocortical Carcinoma - surgery Adult Aged Aged, 80 and over Biological and medical sciences Endocrinopathies Female Humans Laparoscopy Male Malignant tumors Medical sciences Middle Aged Nephrology. Urinary tract diseases Retrospective Studies Treatment Outcome Urology Young Adult |
title | Laparoscopic Versus Open Adrenalectomy for Adrenocortical Carcinoma: Surgical and Oncologic Outcome in 152 Patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T12%3A54%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Laparoscopic%20Versus%20Open%20Adrenalectomy%20for%20Adrenocortical%20Carcinoma:%20Surgical%20and%20Oncologic%20Outcome%20in%20152%20Patients&rft.jtitle=European%20urology&rft.au=Brix,%20David&rft.aucorp=German%20Adrenocortical%20Carcinoma%20Registry%20Group&rft.date=2010-10-01&rft.volume=58&rft.issue=4&rft.spage=609&rft.epage=615&rft.pages=609-615&rft.issn=0302-2838&rft.eissn=1873-7560&rft.coden=EUURAV&rft_id=info:doi/10.1016/j.eururo.2010.06.024&rft_dat=%3Cproquest_cross%3E754028498%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=754028498&rft_id=info:pmid/20580485&rft_els_id=1_s2_0_S0302283810005579&rfr_iscdi=true |